Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

John Mitchell

Concepts (421)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pneumonectomy
40
2024
150
6.320
 Why?
Mycobacterium Infections, Nontuberculous
11
2024
377
3.110
 Why?
Thoracic Surgery
15
2025
122
3.050
 Why?
Esophageal Neoplasms
18
2024
292
2.710
 Why?
Lung Neoplasms
39
2024
2323
2.540
 Why?
Thoracic Surgical Procedures
13
2025
69
2.250
 Why?
Anesthesiology
5
2022
45
1.920
 Why?
Lung Diseases
9
2024
722
1.670
 Why?
Echocardiography, Transesophageal
7
2022
85
1.610
 Why?
Thoracic Surgery, Video-Assisted
11
2022
43
1.590
 Why?
Nontuberculous Mycobacteria
6
2024
228
1.540
 Why?
Esophagectomy
14
2024
123
1.500
 Why?
Carcinoma, Non-Small-Cell Lung
16
2024
1044
1.470
 Why?
Clinical Competence
13
2022
1014
1.390
 Why?
Postoperative Complications
27
2025
2479
1.380
 Why?
Internship and Residency
10
2022
1054
1.350
 Why?
Surgeons
7
2025
274
1.080
 Why?
Bronchiectasis
3
2012
110
1.030
 Why?
Lung Transplantation
7
2019
275
0.980
 Why?
Adenocarcinoma
8
2024
888
0.970
 Why?
Tuberculosis, Pulmonary
3
2018
137
0.970
 Why?
Robotic Surgical Procedures
6
2024
110
0.960
 Why?
Empyema, Pleural
2
2015
12
0.930
 Why?
Societies, Medical
10
2023
749
0.880
 Why?
Neoplasm Staging
15
2024
1288
0.830
 Why?
Humans
134
2025
128524
0.790
 Why?
Central Venous Catheters
1
2022
48
0.740
 Why?
Anesthesiologists
1
2021
12
0.730
 Why?
Education, Medical, Graduate
3
2021
436
0.700
 Why?
Catheterization, Central Venous
1
2022
97
0.690
 Why?
Minimally Invasive Surgical Procedures
6
2024
172
0.660
 Why?
Teaching
3
2021
209
0.650
 Why?
Curriculum
4
2022
921
0.640
 Why?
Ischemic Preconditioning
3
2024
40
0.630
 Why?
Practice Guidelines as Topic
6
2017
1490
0.560
 Why?
Pleura
2
2024
21
0.560
 Why?
Thoracic Wall
1
2017
18
0.550
 Why?
Soft Tissue Infections
1
2017
36
0.540
 Why?
Abscess
1
2017
73
0.530
 Why?
Thoracoscopy
5
2020
51
0.530
 Why?
Tomography, X-Ray Computed
10
2018
2521
0.520
 Why?
Bronchial Fistula
2
2015
4
0.520
 Why?
Pleural Diseases
2
2015
17
0.520
 Why?
Respiratory Tract Fistula
2
2015
7
0.510
 Why?
Anastomosis, Surgical
3
2024
150
0.510
 Why?
Anesthesia
3
2022
129
0.510
 Why?
Thoracotomy
6
2019
74
0.500
 Why?
Laparoscopy
4
2024
454
0.500
 Why?
Databases, Factual
13
2025
1268
0.500
 Why?
Pneumonia, Bacterial
2
2013
109
0.480
 Why?
Osteomyelitis
1
2017
124
0.480
 Why?
Computer Simulation
5
2021
939
0.460
 Why?
Female
65
2025
68127
0.450
 Why?
Male
61
2025
62883
0.450
 Why?
Computer-Assisted Instruction
1
2014
60
0.450
 Why?
Middle Aged
49
2025
30893
0.440
 Why?
Aged
40
2025
21971
0.430
 Why?
Chest Tubes
1
2013
29
0.430
 Why?
Length of Stay
8
2024
1121
0.430
 Why?
Equipment Contamination
1
2013
57
0.430
 Why?
Treatment Outcome
20
2025
10163
0.430
 Why?
Internet
2
2014
618
0.420
 Why?
Tracheobronchomalacia
1
2012
14
0.410
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2024
1565
0.410
 Why?
Anti-Bacterial Agents
6
2024
1667
0.390
 Why?
Retrospective Studies
26
2025
14460
0.390
 Why?
Tuberculosis, Multidrug-Resistant
1
2012
57
0.380
 Why?
Sputum
1
2013
304
0.370
 Why?
Coronary Artery Bypass
2
2015
222
0.360
 Why?
Early Detection of Cancer
1
2015
368
0.350
 Why?
Pneumoperitoneum
1
2010
11
0.350
 Why?
Trachea
3
2022
221
0.350
 Why?
Conversion to Open Surgery
2
2020
15
0.350
 Why?
Mass Screening
2
2015
1152
0.340
 Why?
Combined Modality Therapy
6
2022
1209
0.330
 Why?
Consensus
4
2021
633
0.330
 Why?
Simulation Training
2
2021
82
0.330
 Why?
United States
20
2024
13876
0.320
 Why?
Prospective Studies
12
2024
7043
0.310
 Why?
Specialties, Surgical
2
2023
78
0.300
 Why?
Cost of Illness
1
2010
288
0.290
 Why?
Small Cell Lung Carcinoma
2
2024
88
0.290
 Why?
Heart Diseases
2
2022
345
0.290
 Why?
Workflow
2
2021
149
0.290
 Why?
Educational Measurement
2
2021
261
0.290
 Why?
Mycobacterium avium-intracellulare Infection
1
2008
64
0.280
 Why?
Induction Chemotherapy
2
2024
70
0.270
 Why?
Pleural Neoplasms
2
2024
23
0.270
 Why?
Airway Obstruction
2
2022
149
0.270
 Why?
Diaphragm
2
2023
42
0.260
 Why?
Anesthetics
2
2022
53
0.260
 Why?
Postoperative Care
3
2012
243
0.260
 Why?
Benchmarking
3
2023
176
0.260
 Why?
Patient Satisfaction
1
2010
644
0.260
 Why?
Esophageal Diseases
1
2006
27
0.250
 Why?
Chemoradiotherapy
2
2024
209
0.250
 Why?
Fever
1
2007
301
0.250
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.250
 Why?
Thoracic Neoplasms
1
2005
35
0.240
 Why?
Prognosis
9
2024
3780
0.230
 Why?
Patient Readmission
3
2019
664
0.220
 Why?
Preoperative Care
3
2012
342
0.220
 Why?
Esophagogastric Junction
3
2024
50
0.220
 Why?
Aged, 80 and over
13
2024
7040
0.220
 Why?
Esophageal Stenosis
1
2024
51
0.210
 Why?
Carcinoma, Bronchogenic
1
2003
19
0.210
 Why?
Respiratory Paralysis
1
2023
3
0.210
 Why?
Hypothermia
1
2023
35
0.210
 Why?
Physicians, Women
1
2024
72
0.210
 Why?
Neoplasm Recurrence, Local
4
2024
957
0.210
 Why?
Interleukin-6
1
2007
716
0.210
 Why?
Adult
27
2024
35315
0.210
 Why?
Time-to-Treatment
1
2024
180
0.210
 Why?
Guideline Adherence
2
2024
525
0.210
 Why?
Plasmacytoma
1
2022
16
0.210
 Why?
Tracheal Neoplasms
1
2022
10
0.210
 Why?
Biomedical Research
2
2021
646
0.200
 Why?
Propensity Score
3
2019
261
0.200
 Why?
Bronchi
2
2007
240
0.200
 Why?
Neoplasms, Second Primary
1
2024
108
0.200
 Why?
Cardiovascular Diseases
4
2019
2018
0.200
 Why?
Ascites
1
2002
43
0.200
 Why?
Patient Selection
5
2015
661
0.200
 Why?
Pleural Effusion
1
2002
48
0.200
 Why?
Pain, Postoperative
2
2023
224
0.190
 Why?
Neoadjuvant Therapy
5
2024
380
0.190
 Why?
Endometriosis
1
2002
48
0.190
 Why?
Perioperative Care
2
2016
149
0.190
 Why?
Periodicals as Topic
1
2024
206
0.190
 Why?
Leukemia
1
2024
229
0.190
 Why?
Infectious Disease Transmission, Patient-to-Professional
1
2021
17
0.180
 Why?
Sarcoma
1
2003
177
0.180
 Why?
Interdisciplinary Research
1
2021
26
0.180
 Why?
Technology
1
2021
84
0.180
 Why?
Bronchoscopy
4
2012
208
0.180
 Why?
Disease-Free Survival
4
2024
656
0.180
 Why?
Education, Distance
1
2021
42
0.170
 Why?
Cardiovascular Abnormalities
1
2020
14
0.170
 Why?
Developing Countries
1
2022
283
0.170
 Why?
Subclavian Artery
1
2020
28
0.170
 Why?
Carotid Artery, Common
1
2020
37
0.170
 Why?
Robotics
1
2021
89
0.170
 Why?
Anastomotic Leak
3
2024
38
0.160
 Why?
General Surgery
1
2021
157
0.160
 Why?
Pandemics
3
2023
1487
0.160
 Why?
Survival Rate
5
2024
1872
0.160
 Why?
Quality of Life
3
2024
2680
0.160
 Why?
Stomach
3
2024
109
0.160
 Why?
Metastasectomy
1
2018
21
0.150
 Why?
Pulmonary Emphysema
2
2015
244
0.150
 Why?
Carcinoma, Squamous Cell
3
2012
620
0.150
 Why?
Anesthesia, Cardiac Procedures
1
2017
5
0.150
 Why?
Cohort Studies
5
2019
5369
0.140
 Why?
Negative-Pressure Wound Therapy
1
2017
21
0.140
 Why?
Forms and Records Control
1
2017
22
0.140
 Why?
Pain Management
1
2020
319
0.140
 Why?
Gastric Outlet Obstruction
1
2017
9
0.140
 Why?
Pylorus
1
2017
18
0.140
 Why?
Learning
1
2021
390
0.130
 Why?
Frailty
1
2019
149
0.130
 Why?
NADPH Oxidases
1
2017
108
0.130
 Why?
Clinical Protocols
3
2024
253
0.130
 Why?
Neuromuscular Agents
1
2017
30
0.130
 Why?
Antigen Presentation
1
2017
204
0.130
 Why?
Botulinum Toxins, Type A
1
2017
40
0.130
 Why?
CD4-Positive T-Lymphocytes
2
2017
1046
0.130
 Why?
Extracorporeal Membrane Oxygenation
1
2019
280
0.120
 Why?
Faculty, Medical
1
2018
265
0.120
 Why?
Cause of Death
1
2017
391
0.120
 Why?
Lymphocytes, Tumor-Infiltrating
1
2017
209
0.120
 Why?
Program Development
1
2017
362
0.120
 Why?
Documentation
1
2017
182
0.120
 Why?
Patient-Centered Care
1
2020
493
0.120
 Why?
Risk Factors
7
2024
9727
0.120
 Why?
Kidney Neoplasms
2
2009
349
0.120
 Why?
Radiotherapy Dosage
1
2015
248
0.120
 Why?
Asphyxia
1
2014
21
0.110
 Why?
Chronic Disease
3
2017
1701
0.110
 Why?
Pulmonary Disease, Chronic Obstructive
2
2015
950
0.110
 Why?
Risk
2
2015
852
0.110
 Why?
Chemotherapy, Adjuvant
2
2005
376
0.110
 Why?
Intubation, Intratracheal
1
2016
241
0.110
 Why?
Dyspnea
2
2023
234
0.110
 Why?
Diabetes Mellitus
1
2022
1001
0.110
 Why?
Suture Techniques
2
2006
121
0.110
 Why?
Perfusion
1
2014
188
0.110
 Why?
Myocardial Infarction
1
2021
1014
0.110
 Why?
Health Expenditures
1
2015
184
0.110
 Why?
Patient Discharge
1
2019
849
0.100
 Why?
Group II Phospholipases A2
1
2012
9
0.100
 Why?
Carcinoma, Large Cell
1
2012
15
0.100
 Why?
Mutation
3
2022
3692
0.100
 Why?
Extensively Drug-Resistant Tuberculosis
1
2012
6
0.100
 Why?
Consumer Health Information
1
2013
48
0.100
 Why?
Ultrasonography
1
2016
723
0.100
 Why?
Cardiology
1
2015
267
0.100
 Why?
Time Factors
5
2024
6503
0.100
 Why?
Tracheal Stenosis
1
2012
18
0.100
 Why?
Radiography
1
2014
864
0.100
 Why?
Cost-Benefit Analysis
1
2015
581
0.100
 Why?
B-Lymphocytes
1
2017
820
0.100
 Why?
Volatile Organic Compounds
1
2012
54
0.100
 Why?
ras Proteins
1
2012
145
0.090
 Why?
ErbB Receptors
2
2022
601
0.090
 Why?
Cardiac Surgical Procedures
2
2017
492
0.090
 Why?
Risk Assessment
4
2023
3256
0.090
 Why?
Logistic Models
4
2019
1975
0.090
 Why?
Smoking
2
2017
1463
0.090
 Why?
Physician's Role
1
2013
202
0.090
 Why?
Morbidity
3
2023
302
0.090
 Why?
Tissue and Organ Procurement
1
2014
288
0.090
 Why?
Atrial Flutter
1
2011
35
0.090
 Why?
Antitubercular Agents
1
2012
197
0.090
 Why?
Quality Improvement
4
2020
1100
0.090
 Why?
Mycobacterium Infections
1
2011
62
0.090
 Why?
Oxidative Stress
1
2017
1188
0.090
 Why?
Hemoptysis
1
2010
34
0.090
 Why?
Syndrome
1
2011
335
0.080
 Why?
Patient Reported Outcome Measures
2
2024
359
0.080
 Why?
Neoplasm Invasiveness
3
2024
480
0.080
 Why?
Hospital Costs
1
2010
116
0.080
 Why?
DNA-Binding Proteins
1
2017
1415
0.080
 Why?
Mycobacterium
1
2011
111
0.080
 Why?
Follow-Up Studies
3
2024
4898
0.080
 Why?
Teratoma
1
2010
103
0.080
 Why?
Carcinoma, Papillary
1
2009
77
0.080
 Why?
Enzyme Inhibitors
1
2012
811
0.080
 Why?
Kaplan-Meier Estimate
2
2023
857
0.080
 Why?
Reoperation
2
2008
550
0.080
 Why?
Proto-Oncogene Proteins
1
2012
634
0.080
 Why?
Registries
1
2016
1878
0.080
 Why?
Transcription Factors
1
2017
1631
0.080
 Why?
Lymph Nodes
2
2023
467
0.080
 Why?
Intraoperative Care
1
2008
45
0.070
 Why?
Mountaineering
1
2008
34
0.070
 Why?
Carcinoid Tumor
1
2008
24
0.070
 Why?
Positron-Emission Tomography
2
2009
281
0.070
 Why?
Thrombectomy
1
2008
58
0.070
 Why?
Stents
1
2012
504
0.070
 Why?
Vena Cava, Inferior
1
2008
68
0.070
 Why?
Spectral Karyotyping
1
2007
5
0.070
 Why?
Multivariate Analysis
3
2019
1494
0.070
 Why?
Neoplasm, Residual
1
2008
118
0.070
 Why?
Heart Failure
1
2021
2150
0.070
 Why?
Li-Fraumeni Syndrome
1
2007
13
0.070
 Why?
Respiratory Sounds
1
2008
120
0.070
 Why?
Nephrectomy
1
2008
159
0.070
 Why?
Barrett Esophagus
1
2009
144
0.070
 Why?
Atrial Fibrillation
1
2011
378
0.070
 Why?
Renal Dialysis
1
2011
420
0.070
 Why?
Pyrimidines
1
2010
444
0.070
 Why?
Chromosome Aberrations
1
2007
147
0.070
 Why?
Urinary Bladder Neoplasms
1
2009
226
0.070
 Why?
Surgical Flaps
1
2008
145
0.070
 Why?
Sulfonamides
1
2010
500
0.070
 Why?
Carbonic Anhydrases
1
2006
14
0.060
 Why?
Vascular Surgical Procedures
1
2009
293
0.060
 Why?
Carcinoma, Renal Cell
1
2008
179
0.060
 Why?
Fatigue
2
2023
320
0.060
 Why?
Mediastinoscopy
1
2005
5
0.060
 Why?
Decision Making
1
2013
850
0.060
 Why?
Delivery of Health Care
1
2013
892
0.060
 Why?
Hyaluronan Receptors
1
2006
96
0.060
 Why?
Sialoglycoproteins
1
2006
152
0.060
 Why?
Precancerous Conditions
1
2007
161
0.060
 Why?
Insulin Infusion Systems
1
2009
362
0.060
 Why?
Blood Loss, Surgical
1
2005
91
0.060
 Why?
Hospital Mortality
2
2019
844
0.060
 Why?
Radiotherapy, Adjuvant
1
2005
211
0.060
 Why?
Heart-Lung Transplantation
1
2004
10
0.060
 Why?
Chylothorax
1
2004
15
0.060
 Why?
Odds Ratio
2
2019
1022
0.060
 Why?
Antineoplastic Agents
2
2012
2058
0.060
 Why?
Emergencies
1
2025
162
0.060
 Why?
Diagnosis, Differential
2
2010
1416
0.050
 Why?
Apoptosis
1
2012
2437
0.050
 Why?
Cytogenetic Analysis
1
2003
34
0.050
 Why?
Biomarkers, Tumor
2
2007
1182
0.050
 Why?
Antigens, Neoplasm
1
2006
310
0.050
 Why?
Contraindications
1
2003
88
0.050
 Why?
Constriction, Pathologic
1
2024
229
0.050
 Why?
Evidence-Based Medicine
2
2017
717
0.050
 Why?
Airway Management
1
2022
44
0.050
 Why?
Mesoderm
1
2003
136
0.050
 Why?
Lung
4
2024
3741
0.050
 Why?
Advisory Committees
1
2023
219
0.050
 Why?
Cell Survival
2
2017
1077
0.050
 Why?
Sex Factors
1
2007
1949
0.050
 Why?
Oxygen
1
2006
901
0.050
 Why?
Operating Rooms
1
2022
109
0.050
 Why?
Learning Curve
1
2021
66
0.040
 Why?
Data Warehousing
1
2020
5
0.040
 Why?
Receptor Protein-Tyrosine Kinases
1
2022
221
0.040
 Why?
Socioeconomic Factors
1
2024
1197
0.040
 Why?
Case-Control Studies
2
2024
3326
0.040
 Why?
Intermediate Care Facilities
1
2019
3
0.040
 Why?
Feasibility Studies
2
2015
860
0.040
 Why?
Recurrence
1
2023
1001
0.040
 Why?
Survival Analysis
2
2017
1265
0.040
 Why?
Gene Expression Regulation, Neoplastic
3
2012
1333
0.040
 Why?
Margins of Excision
1
2019
38
0.040
 Why?
Imaging, Three-Dimensional
1
2003
534
0.040
 Why?
Walk Test
1
2019
69
0.040
 Why?
Cytokines
1
2007
1985
0.040
 Why?
Serum Albumin
1
2019
145
0.040
 Why?
Insulin
1
2009
2318
0.040
 Why?
Radiography, Thoracic
2
2010
163
0.040
 Why?
Sarcopenia
1
2019
74
0.040
 Why?
Skilled Nursing Facilities
1
2019
128
0.040
 Why?
Algorithms
1
2005
1616
0.040
 Why?
Lymphocyte Count
1
2017
150
0.030
 Why?
Patient Care Team
1
2022
600
0.030
 Why?
Antigen-Presenting Cells
1
2017
150
0.030
 Why?
NADPH Oxidase 4
1
2017
7
0.030
 Why?
Glutathione Disulfide
1
2017
31
0.030
 Why?
Continuity of Patient Care
1
2019
278
0.030
 Why?
Regression Analysis
1
2019
983
0.030
 Why?
Geography
1
2017
186
0.030
 Why?
Gastric Emptying
1
2017
38
0.030
 Why?
Incidence
1
2023
2619
0.030
 Why?
Inflammation
1
2007
2664
0.030
 Why?
Home Care Services
1
2019
245
0.030
 Why?
Superoxides
1
2017
196
0.030
 Why?
Gastroepiploic Artery
1
2015
4
0.030
 Why?
Cytoplasm
1
2017
258
0.030
 Why?
Immunophenotyping
1
2017
312
0.030
 Why?
Mammary Arteries
1
2015
7
0.030
 Why?
Academic Medical Centers
1
2018
473
0.030
 Why?
Writing
1
2017
94
0.030
 Why?
Radial Artery
1
2015
68
0.030
 Why?
Task Performance and Analysis
1
2016
173
0.030
 Why?
Green Fluorescent Proteins
1
2017
382
0.030
 Why?
Fluorescent Dyes
1
2017
313
0.030
 Why?
Adaptor Proteins, Signal Transducing
1
2017
391
0.030
 Why?
Focus Groups
1
2016
448
0.030
 Why?
Tumor Microenvironment
1
2017
618
0.030
 Why?
Lymphocyte Activation
1
2017
1098
0.030
 Why?
Antioxidants
1
2017
543
0.030
 Why?
Oxidation-Reduction
1
2017
1001
0.030
 Why?
Young Adult
3
2014
12320
0.030
 Why?
Solid Phase Microextraction
1
2012
6
0.030
 Why?
Gas Chromatography-Mass Spectrometry
1
2012
126
0.020
 Why?
Analgesics, Opioid
1
2020
903
0.020
 Why?
Breath Tests
1
2012
89
0.020
 Why?
Gastroscopy
1
2012
18
0.020
 Why?
Silicones
1
2012
23
0.020
 Why?
Foreign-Body Migration
1
2012
34
0.020
 Why?
Biomechanical Phenomena
1
2015
778
0.020
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2012
162
0.020
 Why?
Fibroblasts
1
2017
939
0.020
 Why?
Gene Expression Regulation, Enzymologic
1
2012
283
0.020
 Why?
Cross-Sectional Studies
1
2022
5040
0.020
 Why?
Lymphatic Metastasis
1
2012
318
0.020
 Why?
Gene Expression Profiling
2
2010
1687
0.020
 Why?
Proto-Oncogene Proteins p21(ras)
1
2012
259
0.020
 Why?
Forced Expiratory Volume
1
2012
509
0.020
 Why?
Device Removal
1
2012
137
0.020
 Why?
False Positive Reactions
1
2011
113
0.020
 Why?
Debridement
1
2011
86
0.020
 Why?
Global Health
1
2013
326
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2012
937
0.020
 Why?
Artifacts
1
2011
121
0.020
 Why?
Adolescent
3
2014
20213
0.020
 Why?
Air
1
2010
36
0.020
 Why?
Mice, Knockout
1
2017
2752
0.020
 Why?
Surveys and Questionnaires
1
2022
5346
0.020
 Why?
Blotting, Western
1
2012
1168
0.020
 Why?
Chest Pain
1
2010
89
0.020
 Why?
Indazoles
1
2010
66
0.020
 Why?
Molecular Targeted Therapy
1
2012
387
0.020
 Why?
Attitude of Health Personnel
1
2017
1090
0.020
 Why?
Photochemotherapy
1
2009
32
0.020
 Why?
Diarrhea
1
2010
177
0.020
 Why?
NF-kappa B
1
2012
651
0.020
 Why?
Dose-Response Relationship, Drug
1
2012
1943
0.020
 Why?
Drug Administration Schedule
1
2010
757
0.020
 Why?
Phosphorylation
1
2012
1681
0.020
 Why?
Administration, Oral
1
2010
757
0.020
 Why?
Cisplatin
1
2009
297
0.020
 Why?
Esophagoscopy
1
2009
195
0.020
 Why?
Electrocardiography
1
2011
607
0.020
 Why?
Suicide
1
2014
586
0.020
 Why?
Pilot Projects
1
2012
1558
0.020
 Why?
Decompression, Surgical
1
2008
98
0.020
 Why?
Gene Expression Regulation
1
2017
2506
0.020
 Why?
Carbonic Anhydrase IX
1
2006
4
0.020
 Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2006
19
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2007
313
0.020
 Why?
Biomarkers
1
2017
3881
0.020
 Why?
Osteopontin
1
2006
30
0.020
 Why?
Population Surveillance
1
2009
427
0.020
 Why?
Tegafur
1
2005
3
0.020
 Why?
Platinum Compounds
1
2005
10
0.020
 Why?
Uracil
1
2005
29
0.020
 Why?
Lymphatic Diseases
1
2005
21
0.020
 Why?
Tracheal Diseases
1
2005
16
0.020
 Why?
Catheter Ablation
1
2009
332
0.020
 Why?
Reproducibility of Results
1
2013
3023
0.020
 Why?
Biopsy
1
2009
1085
0.020
 Why?
Mediastinal Neoplasms
1
2005
38
0.020
 Why?
Kidney Failure, Chronic
1
2011
535
0.020
 Why?
Drainage
1
2006
165
0.010
 Why?
Age Factors
1
2012
3117
0.010
 Why?
Cell Line, Tumor
1
2012
3160
0.010
 Why?
RNA, Messenger
1
2012
2674
0.010
 Why?
Lymphoma, Non-Hodgkin
1
2005
76
0.010
 Why?
Meta-Analysis as Topic
1
2005
167
0.010
 Why?
Clone Cells
1
2005
254
0.010
 Why?
Respiratory Mucosa
1
2007
305
0.010
 Why?
Aminocaproates
1
2004
2
0.010
 Why?
Decision Trees
1
2004
89
0.010
 Why?
Oligonucleotide Array Sequence Analysis
1
2006
756
0.010
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2005
334
0.010
 Why?
Sensitivity and Specificity
1
2007
1820
0.010
 Why?
Mediastinum
1
2002
23
0.010
 Why?
Lymph Node Excision
1
2002
165
0.010
 Why?
Hypertension
1
2010
1238
0.010
 Why?
Clinical Trials as Topic
1
2005
998
0.010
 Why?
Cells, Cultured
1
2007
4008
0.010
 Why?
Blood Glucose
1
2009
2092
0.010
 Why?
Animals
1
2017
34501
0.010
 Why?
Mitchell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (421) concept(s)
_
Co-Authors Expand Description
See all (69) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)